SICKLE CELL DISEASE vs. THE CALIFORNIA STEM CELL PROGRAM Disease-a-week Challenge #19
By Don C. Reed
Imagine: inside the veins of an African-American child, red blood cells: round and soft, doing their job, keeping the person alive.
What would happen if those cells hardened and changed shape, curving into the letter C, like a wheat-cutting sickle?
First, the capillaries would clog, in what Sickle Cell Disease (SCD) doctors call a crisis. Excruciating agony, like broken glass in the veins, a crisis may last an hour or a day, and the pain is just the beginning.
By twenty years of age, about 15% of children with SCD suffer major strokes by 40 years of age, almost half have central nervous system damage cognitive dysfunction (mental problems) damage to lungs and kidneys. frequent hospitalizations (and face the likelihood of) early death
Why does this nightmare condition single out African-Americans? The carrier state for SCD may be a defense against malaria, common to sub-Saharan Africa, but the defense is worse than the disease.
Poverty makes things worse: African-Americans are almost three times more likely than whites to be poor, and accordingly lack decent medical insurance:
The U.S. Census declared in 2010 of the population in poverty, 9.9% are white persons, 28.4% are black persons.
Without medical advice, SCD sufferers may not even know even the most basic care: like the vital importance of drinking lots of water to stay well-hydrated.
The more water a person drinks, the less likely it is that their abnormal blood cells will clog
Another effective treatment is a medication called hydroxyurea, which reduces crises by 50% and death by 40%, but most adults are not treated
The problem is getting worse. For a person with sickle cell anemia--
the average life expectancy has (gone down) from 42 in 1995 to 39 today. -- http://www.cirm.ca.gov/...
But doesnt the Affordable Care Act (ACA, or Obamacare) help?
Yes, if your state has it. The Affordable Care Act (ACA) brought reasonably-priced medical care to millions of the poor and middle class. If someone on Obamacare develops SCD, medical care and advice is available to them. This is a wonderful accomplishment, for which history will thank President Obama.
Politics, unfortunately, has gotten in the way.
As originally enacted, the ACA required states to expand Medicaid eligibility to (families)with incomes (close to) the federal poverty levelHowever, a 2012 Supreme Court ruling made it optional for states to expand Medicaid eligibility
As of this writing, 21 state governors (all Republicans) have opted out of ACA: denying affordable medical care to millions of low-income Americans: including all too many families of color.
But access to care is only part of the problem; we also need to have therapies waiting, actual cures to make people wellnot just maintain them in their misery.
Which brings us to three men connected to the California Institute for Regenerative Medicine.
Bert Lubin is a member of the California Stem Cell Agencys board of directors.
If you live in Oakland, California, you might know Dr. Lubin, who for more than thirty-six years has been working to save childrens lives from sickle cell disease.
At the Childrens Hospital of Oakland, Dr. Lubin began the Sibling Donor Cord Blood Program, offered to families across the United States who have a child with a blood disorder such as sickle cell anemiaand who are expecting another child. Following the birth of a healthy child, (his/her cord blood) is harvested. Because cord blood is enriched with blood-forming stem cells, it is cryopreserved (frozen) and can be later used for transplantation. A number of lives have been saved following transplantation with cord blood units collected in this program
A second champion is Dr. Ted Love, who recently retired from the board of the California stem cell program.
Dr. Love is one of the most genuinely charming people you will ever meet, and he has a way of calming down arguments that is amazing to see. When disagreements on the stem cell board got hot and heavy, he could sum up both sides with a gentle voice, allowing problems to be settled amicably. When I told him he would be greatly missed, he said he wanted to dedicate his life to finding a cure for SCD.
How is Dr. Love doing?
Helmed by Bay Area biotech veteran Ted Love, Global Blood Therapeutics is developing treatments for sickle cell disease a genetic blood disorder that in the U.S. affects 1 in 365 African-Americans
The third man is Dr. Donald Kohn of the University of California at Los Angeles (UCLA), recipient of funding from the California stem cell program.
The following are his own words, taken from public documents.
His method?
Isolate some of the patients own marrow and then use gene therapy methods to correct the sickle gene defect in the blood stem cells before transplanting them back into the patient
What would this do?
correction of the sickle mutation in adult bone marrow (blood stem cells) would allow for permanent production of normal red blood cells each red blood cell (RBC) derived will produce normal, non-sickle red blood cells
What are his hopes?
These advances will have direct and immediate applications to enhance current medical therapies of sickle cell disease
Will this information be kept secret, or be shared with other researchers?
All scientific findings and biomedical materials produced from our studies will be publicly available to non-profit and academic organizations in California
The first clinical trial of stem cell gene therapy has begun at UCLA and there are great hopes a new therapy will emerge.Dr. Kohn, personal communication.
The struggle is hard. But it must and will go on, funded by both public and private sources.
In our lifetime, will our scientists make an end to this deadly disease? California intends to find out.
Because black lives matter.
Don C. Reed is the author of the forthcoming book, STEM CELL BATTLES: Proposition 71 and Beyond: How Ordinary People Can Fight Back Against the Crushing Burden of Chronic Disease, available by pre-order from Amazon.com. http://www.worldscientific.com/....
Link:
Sickle Cell Disease vs. the California Stem Cell Agency ...
- Stem Cell Therapy for Treatment of Ocular Disorders - Hindawi - December 27th, 2022
- Researchers find out why some stress is good for you - November 6th, 2022
- Shinya Yamanaka - Wikipedia - October 29th, 2022
- Implanting a Patient's Own Reprogrammed Stem Cells Shows Early Positive ... - October 29th, 2022
- World's first stem cell treatment for spina bifida delivered during fetal surgery - UC Davis Health - October 13th, 2022
- JDRF Announces the Appointment of Qizhi Tang, Ph.D., as Co-Director of The JDRF Center of Excellence in Northern California - PR Newswire - October 13th, 2022
- California court creates regulatory uncertainty over the FDA regulation of stem cell therapies - BioEdge - October 4th, 2022
- Scientists have created a mechanical womb that can grow life in the lab - Inverse - October 4th, 2022
- ISCT: California stem cell ruling is flawed and has inserted regulatory uncertainty into the CGT market - BioPharma-Reporter.com - September 16th, 2022
- Scientists Use Stem Cells to Create Synthetic Mouse Embryos - September 16th, 2022
- UK Equine Research Hall of Fame Inductees Announced - Equi Management - September 16th, 2022
- Cultured meat startup Prolific Machines unveils its Henry Ford approach to cell growth - TechCrunch - September 16th, 2022
- New Stem Cell Therapy Protects Brain Against the Neurological Disorder - Nature World News - September 8th, 2022
- Scientists Are Working on New and Improved Hair Loss Treatments - Gizmodo - September 8th, 2022
- What happens to the brain on prescription steroids? - Medical News Today - September 8th, 2022
- How this scientist uses Legos to explain the power of stem cells - August 30th, 2022
- CIRM Bridges intern researches stem cells to grow kidneys - August 30th, 2022
- Alzheimer's: Could controlling the brain's own clean-up crew help? - Medical News Today - August 22nd, 2022
- Trial to Compare Safety and Efficacy of Novel Cell Therapy to Standard of Care in Patients With Rare Blood Cancers - Curetoday.com - August 5th, 2022
- Medpoint Global was awarded the Best Revolutionary Hair Transplant Center of the Year and continues to follow developments in its field and offer more... - August 5th, 2022
- Cell Culture Media Market Worth $14.64 Billion by 2029 - Exclusive Report by Meticulous Research - GlobeNewswire - August 5th, 2022
- Haifan Lin takes on new role as President of the ISSCR - EurekAlert - July 3rd, 2022
- UCI-led team discovers signaling molecule that potently stimulates hair growth - UCI News - July 3rd, 2022
- Calidi Biotherapeutics Announces Appointment of W.K. Alfred Yung, M.D., to its Medical Advisory Board - Business Wire - July 3rd, 2022
- Organoids reveal similarities between myotonic dystrophy type 1 and Rett syndrome - EurekAlert - July 3rd, 2022
- Our View: Roe reversal hard hit to science - The Durango Herald - July 3rd, 2022
- Connection Map Reveals Changes in the Injured Brain - Technology Networks - June 22nd, 2022
- Scientists Used CRISPR to Trace Every Human Gene to Its Function - Singularity Hub - June 22nd, 2022
- Maike Sander named to lead the Max Delbrck Center - EurekAlert - June 22nd, 2022
- CRISPR-Cas12a Editing Rates Improve with Better Directions to the Nucleus - Genetic Engineering & Biotechnology News - June 22nd, 2022
- UB-led study presents critical step forward in understanding Parkinson's disease and how to treat it - University at Buffalo - June 13th, 2022
- Stem Cells: A Case for the Use of Human Embryos in Scientific Research - June 4th, 2022
- Top Beverly Hills Plastic Surgeon, Dr. John Anastasatos, Explores Cell-Assisted Lipotransfer (CAL) with Breast Augmentation in New Publication -... - June 4th, 2022
- Regenerative Medicine Market To Grow At A CAGR Of 11.27% By 2027, Due To Advancements In Cell Biology, Genomics Research, And Gene-Editing Technology... - June 4th, 2022
- Google Reverses Ban on Ads for All Stem Cell Therapies, Will Allow FDA-Approved Ones - Gizmodo Australia - May 15th, 2022
- Head-To-Head Survey: Jasper Therapeutics (NASDAQ:JSPR) & CytRx (OTCMKTS:CYTR) - Defense World - May 15th, 2022
- Primary Cell Culture Market Mechanical Separation Segment Is Expected To Witness A Lucrative CAGR Of 11.7% Till 2028, Owing To Advancements In... - May 15th, 2022
- Ray Therapeutics Receives $4M in Funding From the California Institute for Regenerative Medicine (CIRM) - BioSpace - May 2nd, 2022
- Predicting the Future of Food - Bon Appetit - May 2nd, 2022
- FDA Grants Direct Biologics Regenerative Medicine Advanced Therapy (RMAT) Designation for the use of ExoFlo in COVID-19 Related ARDS USA - English -... - April 19th, 2022
- Chronic Diseases Is Expected To Have Positive Impact On Stem Cell Characterization Kits Market Demand Bloomingprairieonline - Bloomingprairieonline - April 19th, 2022
- Cleveland Cord Blood Center and Deverra Therapeutics Announce Agreement - Yahoo Finance - April 6th, 2022
- A model that mimics malformation associated with severe epilepsy paves way to novel therapies - EurekAlert - March 25th, 2022
- Stem cell agency: Following the money - and its performance - Capitol Weekly - December 24th, 2021
- Epithelial Cell Culture Media Market to hit US$ 303040.33 thousand by 2028, at 11.4% CAGR: The Insight Partners - Digital Journal - December 24th, 2021
- What is Biohacking? Understanding the Silicon Valley Wellness Trend Youll Hear About in 2022 - SheKnows - December 24th, 2021
- Second Woman Spontaneously Clears HIV: 'We Think More Are Out - Medscape - November 22nd, 2021
- Business Partnership for Development and Commercialization of Medical Device Implant Utilizing MSC2 for the Regeneration of Esophageal Tissue in... - November 22nd, 2021
- Misinformation on stem cell treatments for COVID-19 linked to overhyped science, researchers argue - EurekAlert - October 16th, 2021
- Phase 2 Clinical Trial Data of NurOwn in Progressive MS Will Be Presented at the 37th Congress of the European Committee for Treatment and Research in... - October 16th, 2021
- StemExpress Partners with the Alliance for Regenerative Medicine to Provide COVID-19 Testing for the Cell and Gene Meeting on the Mesa - WSAW - October 5th, 2021
- BrainStorm to Present at the 2021 Cell & Gene Meeting on the Mesa - WWNY - October 5th, 2021
- UC Davis and the School of Medicine set new records in research funding - UC Davis Health - August 31st, 2021
- FDA gives speedy review to Bayer's Parkinson's stem cell therapy - - pharmaphorum - July 21st, 2021
- Stem cell model reveals how COVID-19 can infect the brain - Study Finds - July 21st, 2021
- Introducing the 3D bioprinted neural tissues with the potential to 'cure' human paralysis - 3D Printing Industry - July 21st, 2021
- Insception Lifebank and Cells for Life Join the Generate Life Sciences Family to Create a Global Platform - Canada NewsWire - June 6th, 2021
- Innovative Regenerative Medicine Therapies Safety Comes First - FDA.gov - June 6th, 2021
- ViaCyte to Present Late-Breaking Data at the American Diabetes Association's 81st Scientific Sessions - PRNewswire - June 6th, 2021
- Viral vector unlikely to be cause of leukemia in gene therapy patient - Science Magazine - March 11th, 2021
- Astrocytes Derived from Patients with Bipolar Disorder Malfunction - UC San Diego Health - March 11th, 2021
- Peer Recognition | The UCSB Current - The UCSB Current - March 11th, 2021
- Stem cells on the ballot - Science Magazine - January 20th, 2021
- Controlling the immune system with 'invisible stem' cells - BioNews - January 20th, 2021
- How a UCSF team is giving Cronutt the sea lion a second chance with neuroscience - University of California - October 20th, 2020
- What Proposition 14 Tells Us About California - The New York Times - October 20th, 2020
- California Proposition 14: Funding medical research that uses stem cells - KTLA - October 20th, 2020
- Technology to natures rescue - The Hindu - October 20th, 2020
- What You Need to Know About Prop 14, The Stem Cell Research Bond (Transcript) - KQED - October 5th, 2020
- UC Davis Engineers Lead $36M Effort to Improve Recovery From Spinal Cord Injuries - UC Davis - October 5th, 2020
- Dust off the crystal ball: It's time for STAT's 2020 Nobel Prize predictions - STAT - October 5th, 2020
- Stem Cells Offer Hope of Treatment for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS) - HospiMedica - September 15th, 2020
- David Shavelle, MD, Named Medical Director of Adult Cardiology for the MemorialCare Heart & Vascular Institute at Long Beach Medical Center -... - September 15th, 2020
- Seeing the eye like never before | Newsroom - UW Medicine Newsroom - September 15th, 2020
- Why The FDA's Recent Approval Of New Vaccine Is A Gigantic Win In The War On Cancer - Innovation & Tech Today - September 7th, 2020
- Gore partners with San Diego company on cell delivery system with potential to treat Type 1 diabetes - delawarebusinessnow.com - August 12th, 2020
- Celularity announces the activation of first California Clinical Trial Site following CIRM Grant Award to Advance Treatments for COVID-19 - PRNewswire - August 12th, 2020
- Meet The 12 Next-Gen Food Techs Transforming The Future Of Protein - Green Queen Media - August 12th, 2020
- BeyondSpring Initiates Expanded Access Program with Plinabulin for Patients Suffering from CIN in the US - BioSpace - August 12th, 2020
- BCLI: Phase 3 ALS Data Expected by the End of November 2020 - Yahoo Finance - August 12th, 2020